Searching for cancer-associated gene polymorphisms: promises and obstacles
Evgeny N Imyanitov1, Alexandr V Togo, Kaido P Hanson
1Group of Molecular Diagnostics, N.N. Petrov Institute of Oncology, St.-Petersburg 197758, Russia. evgeny@imyanitoc.spb.ru
Cancer Letters
|January 28, 2004
Summary
Identifying low-penetrance genetic variations for cancer risk involves challenges with numerous single nucleotide polymorphisms (SNPs). Efficiently selecting promising SNPs is crucial for understanding polygenic cancer susceptibility.
Area of Science:
- Genetics
- Cancer Research
- Epidemiology
Background:
- Low-penetrance genetic variations significantly contribute to inherited cancer risk.
- Identifying weak gene-disease interactions and numerous single nucleotide polymorphisms (SNPs) presents substantial research obstacles.
Purpose of the Study:
- To address the challenges in identifying low-penetrance genetic variations associated with cancer risk.
- To optimize the selection of single nucleotide polymorphisms (SNPs) for population analysis and understanding polygenic susceptibility.
Main Methods:
- Leveraging existing genetic databases and functional prediction software to prioritize SNPs.
- Exploring alternative pilot study designs, including non-random patient selection for susceptible individuals.
- Considering accelerated approaches like excluding marginal SNPs and using specific control groups.
Main Results:
- Current methods for extensive case-control studies are limited to a small number of gene polymorphisms.
- Prior studies identifying variability and roles in cancer causation guide SNP selection.
- The validation of accelerated approaches is currently limited by a scarcity of identified low-penetrance risk modifiers.
Conclusions:
- Strategic selection of single nucleotide polymorphisms (SNPs) is paramount for effective cancer risk research.
- Advancements in DNA collections and high-throughput genotyping technologies are expected to accelerate the study of polygenic cancer susceptibility.
- Future research will benefit from refined methodologies for identifying low-penetrance genetic risk factors.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...